The significant increase in the level of CD4+ regulatory T cells in our SLE patients after treatment with RJ may be explained by its immunomodulatory effects through its ability to increase proliferation of immune competent cells (14). The gene discussed is CD4; the disease is systemic lupus erythematosus.